Business Context and Reporting Period
This Form 8-K is a current report filed by Eyenovia, Inc. (not Hyperion Defi, Inc.) on April 1, 2021, regarding events occurring on March 31, 2021. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol "EYEN". The filing reports the appointment of a new independent director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the appointment of Julia A. Haller, M.D. as a member of the Board of Directors, effective March 31, 2021. Dr. Haller is a renowned ophthalmologist and will serve until the 2021 annual meeting of stockholders or until her successor is elected. The Board has determined she is an independent director under SEC and Nasdaq rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It notes that there are no transactions in which the Company participated and in which Dr. Haller had a material interest requiring disclosure under Item 404(a) of Regulation S-K. Dr. Haller has not been appointed to any Board committee at this time.
Investor Verification Checklist
- Verify the correct registrant name is Eyenovia, Inc., not Hyperion Defi, Inc.
- Confirm Dr. Julia A. Haller's independence status and lack of material transactions with the company.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.
- Check subsequent filings for Dr. Haller's assignment to specific Board committees.